Author

Cyril Ronco

Observed names: C. Ronco, C., Ronco, Ronco, Cyril

Institutions: Centre National de la Recherche Scientifique, Inserm, Institut Universitaire de France, Université Côte d'Azur, Université de Lille, Institut Pasteur de Lille, Institut de Chimie de Nice, Médicaments et Molécules pour Agir sur les Systèmes Vivants, Communauté d'universités et d'établissements Université Côte d'Azur

Observed institutions: Centre National de la Recherche Scientifique, Inserm, Institut Universitaire de France, Université Côte d'Azur, Université de Lille, Institut Pasteur de Lille, Institut de Chimie de Nice, Normandie Université, Université Mohammed VI Polytechnique, Laboratoire COBRA, Institut du Cerveau, Médicaments et Molécules pour Agir sur les Systèmes Vivants, Université Nice Sophia Antipolis, Communauté d'universités et d'établissements Université Côte d'Azur, Université de Rouen Normandie, Friedrich Schiller University Jena, Institut National des Sciences Appliquées Rouen Normandie

ORCID: 0000-0002-9023-5940

Observed ORCID: 0000-0002-9023-5940

OpenAlex ID: A5035512825

Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase

2013 · Florian Nachon, Eugénie Carletti, et al. · Biochemical Journal · 499

Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance

2016 · Michaël Cerezo, Abdelali Lehraiki, et al. · Cancer Cell · 274

PDF

Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges

2016 · Antoine Millet, Anthony R. Martin, et al. · Medicinal Research Reviews · 136

ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells

2016 · Cyril Ronco, Anthony R. Martin, et al. · MedChemComm · 134

Human butyrylcholinesterase produced in insect cells: huprine‐based affinity purification and crystal structure

2012 · Xavier Brazzolotto, Marielle Wandhammer, et al. · FEBS Journal · 120

PDF

Recent Advances in Age-Related Macular Degeneration Therapies

2022 · Marie Fabre, Lou Mateo, et al. · Molecules · 101

PDF

Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds

2020 · Oleksandr Grytsai, Oksana Valiashko, et al. · Bioorganic Chemistry · 90

PDF

Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox

2017 · Paul Hermant, Damien Bosc, et al. · Journal of Medicinal Chemistry · 64

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments

2019 · Maeva Dufies, Oleksandr Grytsai, et al. · Theranostics · 61

PDF

Biguanides drugs: Past success stories and promising future for drug discovery

2021 · Oleksandr Grytsai, Iuliia Myrgorodska, et al. · European Journal of Medicinal Chemistry · 51

PDF

Synthesis and structure–activity relationship of Huprine derivatives as human acetylcholinesterase inhibitors

2009 · Cyril Ronco, Geoffroy Sorin, et al. · Bioorganic & Medicinal Chemistry · 49

New Huprine Derivatives Functionalized at Position 9 as Highly Potent Acetylcholinesterase Inhibitors

2011 · Cyril Ronco, Richard Foucault, et al. · ChemMedChem · 44

Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance

2016 · Michaël Cerezo, Abdelali Lehraiki, et al. · Cancer Cell · 43

PDF

Huprine Derivatives as Sub‐Nanomolar Human Acetylcholinesterase Inhibitors: From Rational Design to Validation by X‐ray Crystallography

2011 · Cyril Ronco, Eugénie Carletti, et al. · ChemMedChem · 42

A fluorescent immunochromatographic test using immunoliposomes for detecting microcystins and nodularins

2009 · Nathalie Khreich, Patricia Lamourette, et al. · Analytical and Bioanalytical Chemistry · 39

Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies

2021 · Emilie Jaune, Elisa Cavazza, et al. · Cell Death and Disease · 35

PDF

The GRP78/BiP inhibitor HA15 synergizes with mitotane action against adrenocortical carcinoma cells through convergent activation of ER stress pathways

2018 · Carmen Ruggiero, Mabrouka Doghman-Bouguerra, et al. · Molecular and Cellular Endocrinology · 35

Discovery and Optimization of N-(4-(3-Aminophenyl)thiazol-2-yl)acetamide as a Novel Scaffold Active against Sensitive and Resistant Cancer Cells

2016 · Antoine Millet, Magali Plaisant, et al. · Journal of Medicinal Chemistry · 31

Synthetic accesses to biguanide compounds

2021 · Oleksandr Grytsai, Cyril Ronco, et al. · Beilstein Journal of Organic Chemistry · 30

PDF

Structure–activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme

2014 · Julie Charton, Marion Gauriot, et al. · European Journal of Medicinal Chemistry · 29

Reaction site-driven regioselective synthesis of AChE inhibitors

2013 · Emilia Oueis, Gianluca Santoni, et al. · Organic & Biomolecular Chemistry · 29

Hypoxia inducible factor down-regulation, cancer and cancer stem cells (CSCs): ongoing success stories

2016 · Anthony R. Martin, Cyril Ronco, et al. · MedChemComm · 27

Unified Azoline and Azole Syntheses by Optimized Aza‐Wittig Chemistry

2013 · Patrick Loos, Cyril Ronco, et al. · European Journal of Organic Chemistry · 25

Palladium‐Catalyzed Preparation of N‐Alkylated Tacrine and Huprine Compounds

2010 · Cyril Ronco, Ludovic Jean, et al. · European Journal of Organic Chemistry · 25

Improved synthetic pathway for the derivatization of huprine scaffold

2010 · Cyril Ronco, Ludovic Jean, et al. · Tetrahedron · 24

Works count: 98

Citation count: 2,246

H-index: 24

I10-index: 34